Group 1: Company Performance - In 2024, the company achieved a total operating revenue of 384 million yuan, a year-on-year increase of 7.84% [9] - The net profit attributable to shareholders was 55.5 million yuan, reflecting a year-on-year growth of 9.12% [9] - The company's net profit for the first quarter of 2025 showed a loss of 6.8 million yuan, an increase in loss of 41.61% compared to the previous year [8] Group 2: Research and Development - In 2024, the company invested 41.29 million yuan in R&D, marking a 3.74% increase year-on-year [2] - The company emphasizes continuous R&D investment to support product upgrades and maintain technological leadership in the industry [3][4] Group 3: Market Strategy - The company’s virtual simulation training system accounted for 78.98% of its revenue, indicating a stable market share compared to the previous year [4] - The company is actively expanding its market presence through participation in vocational skill competitions, enhancing brand image and customer interest [5] Group 4: Cost Management - The company has implemented various cost control measures across procurement, production, sales, and management to enhance efficiency and profitability [3] - The company aims to balance revenue structure by diversifying its business areas to mitigate seasonal fluctuations in income [6] Group 5: Future Outlook - The company plans to leverage advancements in AI and digital transformation in vocational education to enhance its service offerings and market competitiveness [10] - The company is committed to a proactive dividend policy, having distributed a total of 183.35 million yuan in cash dividends since its listing, with a plan for further distributions in 2024 [7]

证券代码：300845 证券简称：捷安高科 公告编号：2025-025 郑州捷安高科股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 因公司回购专户股份不参与分红及转增股本，本次权益分派后，按公司总股 本折算，每 10 股现金分红为 3.462760 元（保留小数点后六位，最后一位直接截 取），每 10 股转增股本为 3.957439 股（保留小数点后六位，最后一位直接截取）。 据 此 计 算 除 权 除 息 参 考 价 = （ 股 权 登 记 日 股 票 收 盘 价 -0.3462760 元 ） /(1+0.3957439）。 公司 2024 年年度权益分派方案已获 2025 年 5 月 15 日召开的 2024 年年度股 东大会审议通过，现将权益分派事宜公告如下： 一、股东大会审议通过权益分派方案的情况 1、根据公司 2024 年年度股东大会决议，公司 2024 年度利润分配方案为：以 2024 年度权益分派股权登记日股份数量扣减公司回购专户持有的股份数量后为 基数，向全体股东每 10 股派发现金股利人民币 3 ...

Group 1 - BYD reported August sales of 174,915 new energy vehicles, a year-on-year increase of 184.84% [1] - Cumulative sales from January to August reached 978,795 units, representing a year-on-year growth of 267.31% [1] - The company sold 5,092 new energy passenger vehicles overseas in August [1] Group 2 - Zhongke Electric's subsidiary plans to establish a joint venture with Chongqing Fudi for the production of anode materials, with a registered capital of 1 billion RMB [2] - Zhongke Electric's subsidiary will contribute 650 million RMB, while Chongqing Fudi will contribute 350 million RMB [2] Group 3 - Yuyuan Group intends to transfer 13% of its shares in Jinhuijiu for approximately 1.937 billion RMB, reducing its stake to 25% [3] - The company plans to further reduce its holdings by more than 5% within the next six months [3] Group 4 - Lizhu Group's recombinant COVID-19 fusion protein vaccine has been included in the emergency use for sequential booster immunization [4] Group 5 - Guanghui Energy plans to repurchase shares worth between 800 million and 1 billion RMB to support employee stock ownership plans [5] Group 6 - Cambrian has launched four cloud-based intelligent chips, although mass sales will require a longer time frame and initial technical service investments [7] Group 7 - LePu Medical has received approval from the China Securities Regulatory Commission for the issuance of Global Depositary Receipts (GDRs) and listing on the Swiss Stock Exchange [9] - The GDR issuance will correspond to no more than 180,458,875 new A-shares [9] Group 8 - Fushi Holdings' subsidiary has entered into an exclusive advertising agency cooperation with the Central Radio and Television Station's automotive channel for three years [10] Group 9 - Guangzhou Port's container throughput in August was 1.981 million TEUs, a year-on-year increase of 2.4% [11] - The total cargo throughput for August was 44.788 million tons, a decrease of 0.6% [11] Group 10 - Ningbo Port expects to complete a container throughput of 3.58 million TEUs in August, a year-on-year increase of 10.2% [12] - The total cargo throughput is projected to decline by 3.0% [12] Group 11 - Ming Tai Aluminum reported a 7% year-on-year decrease in aluminum plate and strip sales in August, while aluminum profile sales increased by 47% [13] Group 12 - Electric Power Investment plans to invest in multiple wind and solar projects, with total static investments of 1.585 billion RMB for wind and 538 million RMB for solar [14] Group 13 - Northeast Pharmaceutical has signed a cooperation agreement with MedAbome for the development of the MAb11-22.1 antibody project [19] Group 14 - New Five Feng plans to acquire equity in Tianxin Seed Industry and several other companies for a total price of approximately 2.208 billion RMB [26] Group 15 - Sumeida's subsidiary plans to transfer 100% equity of eight photovoltaic power station project companies, with an estimated transaction value of 657 million RMB [27] Group 16 - *ST Tongzhou intends to acquire 51% equity in Tongtaiwei, fulfilling the capital contribution obligation of 10.2 million RMB [29] Group 17 - Tianyin Holdings' subsidiary plans to invest 120 million RMB in Xundong Xintong to acquire 40% equity [30] Group 18 - Hainan Haiyao plans to publicly transfer 43% equity in Shanghai Lishengte to attract new investors [31] Group 19 - New Asia Process plans to transfer 7.76% of its shares to Xiangcai New Materials at a price of 5.274 RMB per share [32] Group 20 - Lanwei Medical plans to raise no more than 664 million RMB through a private placement for provincial laboratory construction projects [34] Group 21 - Lida New Materials plans to issue convertible bonds to raise no more than 300 million RMB for a new aluminum material project [35] Group 22 - Gekewei has successfully launched its 12-inch CIS integrated circuit project, achieving over 95% yield [51] Group 23 - Baijin Medical's tricuspid valve ring product has received registration approval [52] Group 24 - Shanghai Pharmaceuticals has received approval to initiate Phase I clinical trials for a recombinant anti-CD20 humanized monoclonal antibody [53] Group 25 - Junda Co. has increased the production capacity of its solar cell production base project from 8GW to 10GW [54]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，郑州捷安高科股份有限公司（以下简称 "公司"）定于 2025 年 5 月 22 日（周四）15:25-16:55 参加在全景网举办的河南 辖区上市公司 2025 年投资者网上集体接待日活动，本次活动将采用网络远程的 方式举行，投资者可登录"全景•路演天下"（http://rs.p5w.net）参与本次互动 交流。 出席本次网上集体接待日活动的人员有：董事会秘书、副总经理王建军先生、 证券事务代表贺冬冬先生（如有特殊情况，参会人员将可能进行调整），欢迎广大 投资者积极参与。 特此公告。 证券代码：300845 证券简称：捷安高科 公告编号：2025-024 郑州捷安高科股份有限公司 关于参加河南辖区上市公司 2025 年 投资者网上集体接待日活动的公告 2025 年 5 月 16 日 郑州捷安高科股份有限公司 董事会 ...

证券代码：300845 证券简称：捷安高科 公告编号：2025-023 郑州捷安高科股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、会议召开时间： （1）现场会议时间：2025 年 5 月 15 日（星期四）下午 15:00。 （2）网络投票时间：2025 年 5 月 15 日。 其中：通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 5 月 15 日 9:15—9:25，9:30—11:30 和 13:00—15:00。通过深圳证券交易所互联网投票 系统进行网络投票的时间为 2025 年 5 月 15 日上午 9:15—下午 15:00 期间的任 意时间。 2、会议召开地点： 河南省郑州市高新技术产业开发区雪梅街 56 号公司会议室。 3、会议召开方式： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开的情况 股东大会以现场及网络投票方式举行。 4、会议召集人：公司董事会 5、会议主持人：董事长郑乐观 ...

中国北京建国门外大街 1 号国贸写字楼 2 座 12-15 层 100004 12-15th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 本所同意将本法律意见书作为公司本次股东大会必备的法定文件，随其他文 件一并报送和公告，非经本所书面同意，本法律意见书不得用于其他任何目的或 用途。 北京市通商律师事务所 关于郑州捷安高科股份有限公司 2024 年年度股东大会法律意见书 本所律师按照律师行业公认的业务标准、道德规范和勤勉尽责精神，对本次 股东大会依法进行了见证，并对有关文件和事实进行了必要的核查和验证，现出 致：郑州捷安高科股份有限公司 1 根据《中华人民共和国律师法》《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》《上市公司股东会规则》（以下简称"《股 ...

Market Overview - The ChiNext Index rose by 1.01%, closing at 2083.14 points, with a total trading volume of 369.47 billion yuan, an increase of 1.243 billion yuan compared to the previous trading day [1] - Among the tradable ChiNext stocks, 490 stocks closed higher, with 13 stocks rising over 10%, including Feilida, Hengerd, and Jiean Gaoke, which hit the daily limit [1] Trading Activity - The average turnover rate for the ChiNext today was 3.74%, with 42 stocks having a turnover rate exceeding 20% [1] - The highest turnover rate was for Xinlei Co., which closed up 8.62% with a turnover rate of 61.73% and a trading volume of 1.114 billion yuan [1] - Other notable high turnover stocks included Changhua Chemical and Honggong Technology, with turnover rates of 53.66% and 39.93%, respectively [1] Institutional Activity - In terms of institutional trading, 10 stocks with high turnover rates appeared on the Dragon and Tiger list, indicating significant institutional involvement [2] - Hengxin Life saw a net institutional buy of 45.31 million yuan, while Tianli Technology and Changhua Chemical had net buys of 43.19 million yuan and 41.06 million yuan, respectively [2] Capital Flow - Among high turnover stocks, 21 experienced net inflows of main funds, with the highest inflows seen in Zhongji Huan Ke, Tianli Technology, and Tianyuan Dike, amounting to 244 million yuan, 195 million yuan, and 188 million yuan, respectively [3] - Conversely, stocks like Chenxi Aviation and Aileda experienced significant net outflows, with amounts of 126 million yuan and 88.32 million yuan, respectively [3] Performance Summary - A total of 1 stock among high turnover stocks released a half-year performance forecast, with Zhongjie Automobile expecting a net profit of 48 million yuan, reflecting a year-on-year increase of 4.72% [3] - The performance of stocks with high turnover rates varied, with notable gainers including Feilida and Jiean Gaoke, both hitting the daily limit, while Hengbo Co. and Chenxi Aviation saw declines of 8.49% and 4.07%, respectively [1][3]

Financial Performance - The company achieved operating revenue of 38,388.05 million yuan in 2024, a year-on-year increase of 7.84% [3] - The net profit attributable to shareholders was 5,493.25 million yuan, up 9.12% year-on-year [3] - The net profit after deducting non-recurring gains and losses was 5,276.71 million yuan, reflecting an increase of 11.15% year-on-year [3] - In Q1 2025, operating revenue grew by 4.85%, but net profit attributable to shareholders decreased by 41.61% due to increased depreciation and costs from the stock incentive plan [4] Inventory and Cost Management - The company improved its inventory turnover rate through enhanced inventory management and information technology applications [2] - The decline in gross margin for the emergency safety simulation training system by 13.74% was attributed to changes in market demand and a higher proportion of hardware costs [3] Strategic Initiatives - The company plans to transition from an equipment supplier to a digital service provider in vocational education through the implementation of an AI-based vocational education platform [5] - The digital service model includes comprehensive digital education solutions and intelligent upgrades for training [5] Market Position and Competition - The competitive landscape remains stable, with new competitors entering the market; however, the company leverages over 20 years of industry experience to maintain its market position [6] - The company is optimistic about future industry prospects, driven by national policies promoting digital transformation in vocational education [8] Value Management and Investor Relations - The company emphasizes continuous revenue and profit growth, achieving 3.84 billion yuan in revenue for 2024, a 7.84% increase [10] - A proactive dividend policy has been maintained, with a proposed distribution of 3.5 yuan per 10 shares and a total cash dividend of 183.35 million yuan since listing [10] - The company is committed to transparent information disclosure and enhancing investor relations through various communication channels [12]

证券代码：300845 证券简称：捷安高科 公告编号：2025-022 郑州捷安高科股份有限公司 关于使用部分闲置募集资金及自有资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 郑州捷安高科股份有限公司（以下简称"公司"）于 2025 年 4 月 22 日召开第 五届董事会第十五次会议和第五届监事会第十三次会议，审议通过了《关于使用 部分闲置募集资金及自有资金进行现金管理的议案》，同意公司在不影响募集资 金投资项目建设前提下，使用不超过 8,000 万元人民币的闲置募集资金进行现金 管理，同意公司及子公司（含孙公司）在正常运营前提下使用不超过 30,000 万 元人民币的闲置自有资金进行现金管理，使用期限自公司第五届董事会第十五次 会议审议通过之日起至下一年审议相同事项的董事会召开之日止，在前述额度和 期限范围内资金可以循环滚动使用。公司监事会发表了明确同意意见、保荐机构 民生证券股份有限公司发表了无异议意见，具体内容详见公司在巨潮资讯网披露 的《关于使用部分闲置募集资金及自有资金进行现金管理的公告》（公告编号： 2025-015）。 ...

郑州捷安高科股份有限公司（以下简称"公司"或"本公司"）及董事会全体成 员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。根据深圳证券交易所印发的《深圳证券交易所上市公司自律监管指引第 2 号 -创业板上市公司规范运作》及相关公告格式规定，将本公司 2024 年度募集资金 存放与使用情况报告如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 经中国证券监督管理委员会《关于郑州捷安高科股份有限公司首次公开发行 股票的批复》(证监许可（2020）377 号)核准，公司向社会公众公开发行人民币 普通股 2, 309 万股新股，每股面值人民币 1 元，发行价格为每股人民币 17.63 元， 募集资金总额为人民币407,076,700.00元，扣除发行费用人民币66,905,500.00元， 实际募集资金净额为人民币 340,171,200.00 元。以上募集资金已于 2020 年 7 月 17 日划转至募集资金专用账户。经天健会计师事务所(特殊普通合伙)审验，并出 具了《郑州捷安高科股份有限公司验资报告》【天健验（2020）6-43 号】对上述 募集到账情况进行审验确认。 | ...